SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-020937
Filing Date
2024-01-31
Accepted
2024-01-31 16:19:53
Documents
15
Period of Report
2024-01-30
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d855900d8k.htm   iXBRL 8-K 22148
  Complete submission text file 0001193125-24-020937.txt   173661

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aclx-20240130.xsd EX-101.SCH 3207
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aclx-20240130_def.xml EX-101.DEF 13327
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aclx-20240130_lab.xml EX-101.LAB 21786
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aclx-20240130_pre.xml EX-101.PRE 14083
16 EXTRACTED XBRL INSTANCE DOCUMENT d855900d8k_htm.xml XML 5219
Mailing Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878
Business Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878 240-723-6641
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

IRS No.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41259 | Film No.: 24583178
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)